MMR vaccination and pervasive developmental disorders: A case-control study

Lancet

Volumn 364, Issue 9438, 2004, Pages 963-969

  Smeeth, Liam ^a   Cook, Claire ^a   Fombonne, Prof Eric ^b   Heavey, Lisa ^c   Rodrigues, Prof Laura C ^a   Smith, Prof Peter G ^a   Hall, Prof Andrew J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

AGE DISTRIBUTION; ARTICLE; AUTISM; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; EARLY DIAGNOSIS; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; UNITED KINGDOM; VACCINATION;

EID: 4444290427     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)17020-7     Document Type: Article

References (47)

1. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 351:1998;637-641
2. Wakefield AJ, Anthony A, Murch SH, et al. Enterocolitis in children with developmental disorders. Am J Gastroenterol. 95:2000;2285-2295
3. Furlano RI, Anthony A, Day R, et al. Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J Pediatr. 138:2001;366-372
4. Wakefield AJ, Montgomery SM. Measles, mumps, rubella vaccine: Through a glass, darkly. Adverse Drug React Toxicol Rev. 19:2001;265-283
5. Uhlmann V, Martin CM, Sheils O, et al. Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol. 55:2002;84-90
6. Smeeth L, Hall A, Rodrigues L, Cook C, Fombonne E. Autism, bowel inflammation, and measles. Lancet. 359:2002;2112-2113
7. Taylor B, Miller E, Farrington CP, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet. 353:1999;2026-2029
8. Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med. 347:2002;1477-1482
9. Wilson K, Mills E, Ross C, McGowan J, Jadad A. Association of autistic spectrum disorder and the measles, mumps, and rubella vaccine: a systematic review of current epidemiological evidence. Arch Pediatr Adolesc Med. 157:2003;628-634
10. Loff B, Cordner S. Australia's measles campaign challenged. Lancet. 352:1998;1368
11. Burton D. Opening statement by the Chairman. Government Reform Committee United States House of Representatives. Autism: present challenges, future needs - why the increased rates? Washington DC: Committee on Government Reform, 2000.
12. Ramsay ME, Yarwood J, Lewis D, Campbell H, White JM. Parental confidence in measles, mumps and rubella vaccine: evidence from vaccine coverage and attitudinal surveys. Br J Gen Pract. 52:2002;912-916
13. Department of Health. Statistical bulletin. NHS Immunisation Statistics, England. 2002-03. http://www.publications.doh.gov.uk/public/sb0316.htm (accessed Aug 31, 2004).
14. Report from the Director of Public Health, NHS London Regional Office. Measles in London: incidence and current action. London: Greater London Authority; 2002.
15. Jansen VA, Stollenwerk N, Jensen HJ, Ramsay ME, Edmunds WJ, Rhodes CJ. Measles outbreaks in a population with declining vaccine uptake. Science. 301:2003;804
16. Smeeth L, Hall AJ, Fombonne E, Rodrigues LC, Huang X, Smith PG. A case-control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodology. BMC Public Health. 1:2001;2
17. Walley T, Mantgani A. The UK General Practice Research Database. Lancet. 350:1997;1097-1099
18. Office for National Statistics. Key health statistics from general practice 1996 (Series MB6 No. 1). London: Office for National Statistics; 1998.
19. Nazareth I, King M, Haines A, Rangel L, Myers S. Accuracy of diagnosis of psychosis on a general practice computer system. BMJ. 307:1993;32-34
20. van Staa T, Abenhaim L. The quality of information recorded on a UK database of primary care records: a study of hospitalisations due to hypoglycaemia and other conditions. Pharmacoepid Drug Safety. 3:1994;15-21
21. Hollowell J. The General Practice Research Database: quality of morbidity data. Popul Trends 1997: 36-40.
22. Salisbury DM, Begg NT. Immunisation against infectious disease. 1996;HM Stationery Office, London
23. Clayton D, Hills M. Conditional logistic regression. Statistical models in epidemiology. 1993;290-297 Oxford University Press, Oxford
24. Rapin I. Autism. N Engl J Med. 337:1997;97-104
25. Fombonne E, Heavey L, Smeeth L, et al. Validation of the diagnosis of autism in general practitioner records. BMC Public Health. 4:2004;5
26. Fine PE, Chen RT. Confounding in studies of adverse reactions to vaccines. Am J Epidemiol. 136:1992;121-135
27. Spitzer WO. Measles, mumps, and rubella vaccination and autism. N Engl J Med. 348:2003;951-952
28. Fombonne E, Chakrabarti S. No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics. 108:2001;E58
29. Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ. 324:2002;393-396
30. MMR vaccine - how effective and how safe? Drug Ther Bull 2003; 41: 25-29.
31. Jefferson T, Price D, Demicheli V, Bianco E. Unintended events following immunization with MMR: a systematic review. Vaccine. 21:2003;3954-3960
32. Miller E. Measles-mumps-rubella vaccine and the development of autism. Semin Pediatr Infect Dis. 14:2003;199-206
33. DeStefano F, Thompson WW. MMR vaccine and autism: an update of the scientific evidence. Expert Rev Vaccines. 3:2004;19-22
34. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 22:1959;719-748
35. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials. 7:1986;177-188
36. Jick H, Kaye JA, Black C. Changes in risk of autism in the U.K. for birth cohorts 1990-1998. Epidemiology. 14:2003;630-632
37. Jick H, Kaye JA. Epidemiology and possible causes of autism. Pharmacotherapy. 23:2003;1524-1530
38. DeStefano F, Bhasin TK, Thompson WW, Yeargin-Allsopp M, Boyle C. Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan atlanta. Pediatrics. 113:2004;259-266
39. Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltola H. Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J. 19:2000;1127-1134
40. Farrington CP, Miller E, Taylor B. MMR and autism: further evidence against a causal association. Vaccine. 19:2001;3632-3635
41. DeWilde S, Carey IM, Richards N, Hilton SR, Cook DG. Do children who become autistic consult more often after MMR vaccination? Br J Gen Pract. 51:2001;226-227
42. Makela A, Nuorti JP, Peltola H. Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics. 110:2002;957-963
43. Gillberg C, Heijbel H. MMR and autism. Autism. 2:1998;423-424
44. Dales L, Hammer SJ, Smith NJ. Time trends in autism and in MMR immunization coverage in California. JAMA. 285:2001;1183-1185
45. Kaye JA, Mar Melero-Montes M, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ. 322:2001;460-463
46. Geier DA, Geier MR. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. Med Sci Monit. 10:2004;I33-I39
47. Chen W, Landau S, Sham P, Fombonne E. No evidence for links between autism, MMR and measles virus. Psychol Med. 34:2004;543-553